Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Barbara Cullinane .
Filed returns
6
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meeting to discuss AstraZeneca’s footprint in Ireland and Europe and related policy issues (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Pinnacle Public Affairs Ltd | Health | Cardiovascular Health Policy in EU (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Irish Pharmaceutical Healthcare Association | Health | Agenda of the EU Competitiveness Council (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Novo Nordisk Limited | Health | To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Revision of the European Pharmaceutical Legislation (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2022 | Irish Cancer Society | Health | Cancer screening services (Public policy or programme) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 6 | 100.0% |